[10] Within a year after stopping treatment with tirzepatide for obesity, people on average regain more than half the weight they lost during treatment, [25] [26] and return to their previous weight within a year and a half
Manufacturers increasingly require specialized ingredient combinations, slower-fermentation fibers, and low-irritation delivery systems, significantly increasing product development timelines, sourcing complexity, and formulation costs within the market
Why does real-world evidence diverge so sharply from clinical trial withdrawal studies
But the mistake that the Trump administration made was in sharing preliminary results and then having to issue a seemingly contradictory statement shortly afterward
Americans are increasingly seeking innovative therapies for aging, chronic pain and longevityoften faster than science can provide definitive answers
The category has been buoyed by clinical research as well